NICE Endorses Semaglutide to Reduce Cardiovascular Risk



Semaglutide recommended for NHS use in England to reduce heart attack and stroke risk in high-risk adults.
Medscape News UK



Source link : https://www.medscape.com/viewarticle/nice-endorses-semaglutide-reduce-cardiovascular-risk-2026a10009xq?src=rss

Author :

Publish date : 2026-04-01 13:52:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version